Research ArticleArticle
Open Access
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
RONALD F. van VOLLENHOVEN, PAUL EMERY, CLIFTON O. BINGHAM III, EDWARD C. KEYSTONE, ROY FLEISCHMANN, DANIEL E. FURST, KATHERINE MACEY, MARIANNE SWEETSER, ARIELLA KELMAN and RAVI RAO
The Journal of Rheumatology March 2010, 37 (3) 558-567; DOI: https://doi.org/10.3899/jrheum.090856
RONALD F. van VOLLENHOVEN
PAUL EMERY
CLIFTON O. BINGHAM III
EDWARD C. KEYSTONE
ROY FLEISCHMANN
DANIEL E. FURST
KATHERINE MACEY
MARIANNE SWEETSER
ARIELLA KELMAN
REFERENCES
- 1.↵
- Genovese MC,
- Bathon JM,
- Fleischmann RM,
- Moreland LW,
- Martin RW,
- Whitmore JB,
- et al.
- 2.↵
- Maini RN,
- Breedveld FC,
- Kalden JR,
- Smolen JS,
- Furst D,
- Weisman MH,
- et al.
- 3.↵
- Schiff MH,
- Burmester GR,
- Kent JD,
- Pangan AL,
- Kupper H,
- Fitzpatrick SB,
- et al.
- 4.↵
- 5.↵
- Bongartz T,
- Sutton AJ,
- Sweeting MJ,
- Buchan I,
- Matteson EL,
- Montori V
- 6.↵
- Kroesen S,
- Widmer AF,
- Tyndall A,
- Hasler P
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- Maloney DG,
- Grillo-López AJ,
- White CA,
- Bodkin D,
- Schilder RJ,
- Neidhart JA,
- et al.
- 11.↵
- Cohen SB,
- Emery P,
- Greenwald MW,
- Dougados M,
- Furie RA,
- Genovese MC,
- et al.
- 12.↵
- Emery P,
- Fleischmann R,
- Filipowicz-Sosnowska A,
- Schechtman J,
- Szczepanski L,
- Kavanaugh A,
- et al.
- 13.↵
- 14.↵
- Sell S,
- Max EE
- 15.↵
- 16.↵
- Emery P,
- Rigby WF,
- Combe B,
- Latinis K,
- Szczepanski LJ,
- Roschmann RA,
- et al.
- 17.↵
- Rubbert-Roth A,
- Tak PP,
- Bombardieri S,
- Zerbini C,
- Tremblay J,
- Carreño L,
- et al.
- 18.↵
- Mease PJ,
- Cohen S,
- Gaylis NB,
- Chubick A,
- Kaell AT,
- Greenwald M,
- et al.
- 19.↵
- Bingham C,
- Looney R,
- Deodhar A,
- Halsey N,
- Greenwald M,
- Codding C,
- et al.
- 20.↵
- Keystone EC,
- Fleischmann R,
- Emery P,
- Chubick A,
- Dougados MR,
- Baldassare AR,
- et al.
- 21.↵
- Centers for Disease Control/National Center for Health Statistics
- 22.↵
- Moreland LW,
- Weinblatt ME,
- Keystone EC,
- Kremer JM,
- Martin RW,
- Schiff MH,
- et al.
- 23.↵
- Genovese MC,
- Schiff M,
- Luggen M,
- Becker JC,
- Aranda R,
- Teng J,
- et al.
- 24.↵
- 25.↵
- Wolfe F,
- Michaud K,
- Chakravarty EF
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- Dixon WG,
- Watson KD,
- Lunt M,
- Hyrich KL,
- British Society for Rheumatology Biologics Register Control Centre Consortium
- 36.↵
- Solomon DH,
- Goodson NJ,
- Katz JN,
- Weinblatt ME,
- Avorn J,
- Setoguchi S,
- et al.
- 37.↵
- 38.↵
- 39.↵
- 40.↵
- Burmester GR,
- Mariette X,
- Montecucco C,
- Monteagudo-Sáez I,
- Malaise M,
- Tzioufas AG,
- et al.
In this issue
The Journal of Rheumatology
Vol. 37, Issue 3
1 Mar 2010
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
RONALD F. van VOLLENHOVEN, PAUL EMERY, CLIFTON O. BINGHAM, EDWARD C. KEYSTONE, ROY FLEISCHMANN, DANIEL E. FURST, KATHERINE MACEY, MARIANNE SWEETSER, ARIELLA KELMAN, RAVI RAO
The Journal of Rheumatology Mar 2010, 37 (3) 558-567; DOI: 10.3899/jrheum.090856
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
RONALD F. van VOLLENHOVEN, PAUL EMERY, CLIFTON O. BINGHAM, EDWARD C. KEYSTONE, ROY FLEISCHMANN, DANIEL E. FURST, KATHERINE MACEY, MARIANNE SWEETSER, ARIELLA KELMAN, RAVI RAO
The Journal of Rheumatology Mar 2010, 37 (3) 558-567; DOI: 10.3899/jrheum.090856